Skip to content

Target Tetra TG5412560Recalls & reported problems

Stryker Corporation · Detachable Coil · Class 2 · Implant

All models of Target Tetra (19)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
7
Deaths reported
0
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 07613327578638), received between Apr 18, 2024 and Sep 18, 2026 — classified as 3 injuries, 4 malfunctions.

The most frequently reported specific device problem is “Premature Separation” (4 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 1 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 2 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 1 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 2 reportsSep 2026: 1 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Premature Separation4
  • Migration2
  • Fracture1

Patient problems

  • No Clinical Signs, Symptoms or Conditions6
  • Muscle Weakness/Atrophy1
  • Obstruction/Occlusion1
  • Speech Disorder1
  • Stroke/CVA1

Recent adverse event reports

The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 18, 2026Premature Separation

    It was reported that the subject coil advanced through the microcatheter into the middle meningeal artery (MMA) but the subject coil would not deploy. However, The subject coil was returned for analysis and the device investigation revealed that the main coil prematurely detached/separated during use. There is no additional information available.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50819212 ↗
  • MalfunctionAug 26, 2026Premature Separation

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50464492 ↗
  • InjuryAug 17, 2026Premature Separation

    It was reported that during procedure, the subject coil got prematurely detached in the microcatheter and the subject coil got retrieved out by using guidewire and it was found to be stretched. The procedure was completed successfully. No clinical consequences were reported to the patient due to this event.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50287865 ↗
  • MalfunctionNov 6, 2025Premature Separation; Premature Separation

    IT WAS REPORTED THAT DURING THE COIL EMBOLIZATION PRIOR TO THE EVAR ENDOVASCULAR ANEURYSM REPAIR, WHEN ADVANCING THE SUBJECT COIL WITHIN A MICROCATHETER, RESISTANCE WAS ENCOUNTERED IN THE MIDDLE OF THE SHAFT, AND THE COIL GOT STUCK THERE. WHEN RETRIEVING THE SUBJECT COIL, IT GOT PREMATURELY DETACHED WITHIN THE MICROCATHETER. THEREFORE, THE ENTIRE MICROCATHETER WAS REMOVED FROM THE BODY. THE SUBJECT DEVICE WAS REPLACED, AND THE PROCEDURE WAS COMPLETED SUCCESSFULLY. NO CLINICAL CONSEQUENCES WERE REPORTED TO THE PATIENT DUE TO THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23493312 ↗
  • InjuryMar 17, 2025Migration; Migration

    IT WAS REPORTED THAT 4 MONTHS AFTER SUCCESSFUL SUBJECT COIL IMPLANTATION PROCEDURE FOR A CEREBRAL ANEURYSM, PATENT SUFFERED ACUTE RIGHT LEG WEAKNESS, DIFFICULTY SPEAKING, OBSTRUCTION AND FOUND TO HAVE A STROKE. STROKE WAS CAUSED BY THE SUBJECT COIL THAT HAD MIGRATED OUT OF THE ANEURYSM AND TRAVELLED DISTALLY INTO ANTERIOR CEREBRAL ARTERY. PATIENT UNDERWENT CATHETER ANGIOGRAM, MULTIPLE IMAGING STUDIES AND AN INCREASE ANTI-THROMBOTIC MEDICATION. SHE HAS HAD A STROKE, IS DISABLED FROM LEG WEAKNESS RESULTING FROM COIL MIGRATION.

    Patient problems: Muscle Weakness/Atrophy; Obstruction/Occlusion; Speech Disorder; Stroke/CVA

    MAUDE report 21626709 ↗
  • MalfunctionMar 7, 2025Fracture; Fracture

    THE COIL (SUBJECT DEVICE) WAS RETURNED FOR ANALYSIS, AND IT WAS DISCOVERED THAT THE MAIN COIL (SUBJECT DEVICE) WAS BROKEN/FRACTURED DURING USE. THERE WAS A SLIGHT DELAY IN SURGERY DUE TO THE EVENT. THE SUBJECT DEVICE WAS REPLACED, AND THE PROCEDURE WAS COMPLETED SUCCESSFULLY. NO CLINICAL CONSEQUENCES WERE REPORTED TO THE PATIENT DUE TO THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21548582 ↗
  • InjuryApr 18, 2024Migration; Migration

    IT WAS REPORTED THAT DURING A RUPTURED ANTERIOR COMMUNICATING ARTERY ANEURYSM BALLOON ASSISTED COILING PROCEDURE, THE SUBJECT COIL APPEARED TO BE STABLE DURING INITIAL COILING AND ON FINAL ANGIOGRAM FOLLOWING THE TREATMENT. PHYSICIAN PERFORMED A COMPUTED TOMOGRAPHY HOURS AFTER TREATMENT AND SUBJECT COIL TAIL WAS FOUND PROTRUDING FROM THE ANEURYSM INTO THE A1. A SECOND BALLOON ASSISTED COIL PROCEDURE WAS DONE TO SECURE THE ANEURYSM. THE PATIENT IS IN CRITICAL CONDITION DUE TO PULMONARY ISSUES.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19140214 ↗

Other DEVICE, NEUROVASCULAR EMBOLIZATION devices

All DEVICE, NEUROVASCULAR EMBOLIZATION devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page